HIGHMARK APPOINTS DMYTRO P. YEVTUSHENKO, PHD. AS SCIENTIFIC ADVISOR
Highmark Marketing Inc. has appointed Dr. Dmytro P. Yevtushenko, PhD, as scientific adviser.
Dr. Dmytro P. Yevtushenko is an accomplished scientist in the area of plant biology and biotechnology. He holds a PhD in cell biology from the Institute of Cell Biology & Genetic Engineering, and an MSc in plant physiology and biochemistry (with distinction) from Kiev State University, Ukraine. Dr. Yevtushenko’s research has focused on crop improvement and food safety using modern techniques of molecular biology, genetic engineering and plant tissue culture. In addition, he has a comprehensive knowledge and interest in metabolic bioengineering, secondary metabolite pathways, gene regulation and bioinformatics.
In Dr. Yevtushenko’s past position as director of research and development at Provitro Biosciences LLC, a plant biotechnology company in Mount Vernon, Wash., United States, he worked on the development and implementation of innovative research programs in plant cell and tissue culture. He previously worked as a research associate in the Centre for Forest Biology and senior scientist at SynGene Biotek Inc., department of biochemistry and microbiology at the University of Victoria, B.C., Canada.
Dr. Yevtushenko is the author of over 50 publications, including research articles published in peer-reviewed scientific journals. He has presented major research achievements at numerous scientific conferences, symposia and meetings. He holds two patents, which are on methods to increase plant yield.
As scientific adviser, Dr. Yevtushenko has agreed to provide Highmark with industry intelligence and updates, and to work closely with management to develop business strategies that take advantage of current and future market opportunities.
According to Health Canada, a licensed producer of marijuana must have an employee designated as a quality assurance person who is responsible for assuring the quality of dried marijuana. Highmark is not a licensed producer of marijuana, but it announced in a news release dated June 24, 2014, that it had entered into a binding letter of intent with BCBUD Producers Inc. to acquire 100 per cent of the authorized share capital of BCBUD. BCBUD has an option to lease a 27,000-square-foot building in the township of Langley, B.C. The property is zoned M-2, and when the facility is operational, it could be capable of producing up to two million grams (4,409 pounds) of medical marijuana per year, with the additional possibility of expansion adjacent to the site. BCBUD has prepared an application to become a licensed producer. It is not known if and when BCBUD will obtain the requisite licence. The key milestones to obtaining the licence include filing an application, receiving a ready-to-build notice, completion of the upgrades as per the application, approval to produce upon inspection of the facility and finally approval to distribute the product to patients. If Highmark does become a licensed producer of marijuana, Dr. Yevtushenko will assist Highmark with fulfilling its quality assurance requirements under the Marihuana for Medical Purposes Regulations (MMPR) program.
In addition, and more specifically, the scientific adviser has agreed to make his knowledge and expertise available to advising Highmark regarding research and development on marijuana and marijuana strains, as well as advising on research and development methods with the view to improving yield. Any research and development concerning marijuana may be subject to necessary governmental approval.
As consideration for services provided, Highmark will grant Dr. Yevtushenko, in accordance with the company’s stock option plan, an incentive stock option to purchase 50,000 common shares in the capital of Highmark.
Highmark looks forward to working with Dr. Yevtushenko and learning from his expertise to further Highmark’s business in the medical marijuana sector.
July 9, 2014, news release
Highmark would also like to revise the news release dated July 9, 2014, which announced the close of the first tranche of a non-brokered private placement. Finders were inadvertently described as agents. All other content of that news release remains unchanged.
We seek Safe Harbor.
© 2014 Canjex Publishing Ltd. All rights reserved.
- Published in Medical Marijuana
Affinor Growers Announces Management Integration
Affinor Growers (CSE:AFI)(OTCQB:RSSFF)(FRANKFURT:1AF) (“Affinor” or the “Corporation) integrates COO from Vertical Designs Ltd. As part of the intended integration of Vertical Design Ltd into Affinor Growers, CEO Sebastien Plouffe and Chairman of the Board Nick Brusatore have appointed Jarrett Malnarick as Chief Operating Officer, effective immediately.
Malnarick replaces former COO Tegan Adams, who is moving to an agricultural operations consulting role following her hard work establishing due diligence, market analysis, and operational plans for Affinor’s growing roster of facilities and projects.
The move helps integrate Malnarick into Affinor’s operations in a position that makes full use of his working knowledge of VDL’s technology. Malnarick will report to the CEO and Chairman.
Malnarick will assume responsibility for operations, alignment and prioritization of company developments, acquisitions and projects. He is known for his hands on approach and has over 15 years experience in product development, retail logistics, operational systems development, effective team building and regulatory compliance.
While with Vertical Designs, Malnarick was responsible for managing operations and assisting CEO Nick Brusatore with corporate strategy. In that role he helped to fund several technological developments, managed third party validation, conducted market analysis, patent applications, license agreements and independent evaluations for the company setting the platform for effective acquisition.
Malnarick ran his own successful consulting company for over 10 years assisting companies with acquisitions, product development, design costing and ROI analysis, organizational budgets, developmental funding through grants and tax credit programs, new facility process planning, quality engineering and product regulatory compliance to Health Canada and international standards through the design and implementing operational systems. He originally worked with Vertical Designs Ltd. as a consultant and later joined their team in 2011.
Malnarick has held a number of executive positions and has earned a Bachelor of Science from the University of Victoria.
Adams said of the change, “It’s been a wonderful experience working with the Affinor team, and I’m proud to have helped the company surge forward in the way it has. The role I enjoyed at the company has put me in touch with a lot of interesting projects and companies, and the reputation I’ve built while at the organization makes this the perfect time to make the step to consulting. I will continue to be in contact with the Affinor team and remain open to working with the company down the road as needed.”
Sebastien Plouffe, President & CEO says of the appointment, “This reorganization is important for Affinor Growers, as we will be relying on VDL technology heavily and nobody knows the system better than Jarrett. I’d like to personally thank Tegan Adams for her devoted effort and energy that she brought to Affinor during her time as COO, and she will always be a part of the Affinor family.”
About Affinor Growers Inc.
Affinor Growers is a diversified publicly traded company on the Canadian Securities Exchange under the symbol (“AFI”). Affinor is focused on growing high quality crops such as romaine lettuce, spinach, strawberries and high quality medical Marijuana. Affinor is committed to becoming a pre-eminent grower, using exclusive vertical farming techniques.
On Behalf of the Board of Directors
AFFINOR GROWERS INC.
“Sebastien Plouffe”
President & CEO
The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release
FORWARD LOOKING INFORMATION
This News Release contains forward-looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com. This News Release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.
- Published in Medical Marijuana
Affinor Growers Completes 45-Acre Land and Facilities Acquisition in Quebec to Produce Strawberries
MONTREAL, CANADA — (Marketwired) — 07/21/14 — Affinor Growers (CSE:AFI)(OTCQB:RSSFF)(FRANKFURT:1AF) (“Affinor” or the “Corporation) has purchased 45 Acres of agriculture property in St-Chrysostome, Quebec, for $340,000.
An offer has been accepted on the 45 acres of prime land south of Montreal and Affinor Growers plans to build a state-of-the-art, strawberry-growing facility in St-Chrysostome, Quebec.
Sebastien Plouffe, president and CEO, comments: “This acquisition is strategically perfect for our distribution plans because it’s located about 30 minutes from Montreal and only few kilometers from the New-York State Border. We’re proud to be able to build the facitliy in the Province of Quebec renowned for it’s agriculture experts and know-how. The Quebec provincial government has incentives for investment into agriculture and job creation, and the Affinor Growers team is excited to explore ways to best collaborate and expand into such a unique culture in Canada. We will be very proactive to begin construction of this facility to satisfy our future clients.”
Update on Affinor Growers:
After completion of due diligence, the Affinor Growers board of directors have decided not to proceed with the LOI signed and announced on June 9, 2014. Fab-All will still continue to build parts for the Vertical Design equipment as Fab-All produces excellent, high quality products.
Affinor Growers will also not complete the land acquistion in Saskatchewan and will instead concentrate it’s effort on building a facility in St-Chrysostome, Quebec and to complete the acquisition of the Vancouver rooftop garden.
About Affinor Growers Inc.
Affinor Growers is a diversified publicly traded company on the Canadian Securities Exchange under the symbol (“AFI”). Affinor is focused on growing high quality crops such as romaine lettuce, spinach, strawberries and high quality medical Marijuana. Affinor is committed to becoming a pre-eminent grower, using exclusive vertical farming techniques.
On Behalf of the Board of Directors AFFINOR GROWERS INC. "Sebastien Plouffe" President & CEO
The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release
FORWARD LOOKING INFORMATION
This News Release contains forward-looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com. This News Release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.
Contacts:
Contact Information
Sebastien Plouffe
President & CEO
(514) 947-2272
splouffe@affinorgrowers.com
http://www.affinorgrowers.com/en
Contact Information
Momentum PR Inc
Max Gagne, President
(514) 913-0351
max@momentumpr.com
Contact Information, spokesperson
Vertical Designs Ltd
Nick Brusatore, CEO
(604) 356-0411
nbrusatore@gmail.com
- Published in Medical Marijuana
DUNDEE SUSTAINABLE TECHNOLOGIES INC. DEVELOPMENT IN FERTILIZER BUSINESS
MONTREAL, QUEBEC–(Marketwired – July 14, 2014) – Dundee Sustainable Technologies Inc. (“DST” or the “Corporation”) (CSE:DST), the developer and owner of proprietary technologies to serve the natural resource sector with environmentally friendly procedures, is pleased to announce its commitment in the fertilizer business.
DST has obtained patents for the production of sulfate based fertilizers. These processes are providing a new way to the industry of producing potassium sulfate (“SOP” or K2S04) and potassium magnesium sulfate (“SOPM” or K2SO4.2MgSO4). Both products are accompanied by the production of salable hydrochloric acid as a by-product.
Sulfate based fertilisers are applied at sowing time, where ions are adsorbed in the soil and remain available and protected against leaching. The growing need to do more with less, and the sulfur deficiency in particular crops have led to an increase use of sulfate based fertilisers, while excess use of chloride based fertilisers (potassium chloride or “potash”) reduces nutrient uptake and yield quantities, water soluble sulfate fertilisers such as SOP and SOPM are the most effective for growing crops.
The growing market for sulfate based fertilisers along with depleting natural sources of chloride-free potassium creates a great opportunity for DST to develop its patented processes.
DST has analyzed a project to build a plant for the production of SOP using potash and sulfuric acid. Moreover, DST has received interest from a North American distributor that is ready to market the production of 50,000 tonnes per year of SOPM and could also be interested in SOP.
Market
The current market conditions and specific demands from the fertilizer market are opening a window of opportunities to launch projects that would lead to the construction of fertilizer plants. DST’s technology allows for SOP and SOPM to be produced below current market price with profit margins preliminary estimated at $410 per tonne for SOP and $225 per tonne for SOPM.
The National Research Council of Canada granted DST a $50,000 subsidy for the assessment of its fertilizer technology.
About Dundee Sustainable Technologies, a company controlled by Dundee Corporation
The cyanide and mercury free gold extraction process developed by DST, has been recognized as a “green technology” for which DST has been awarded $5,700,000 in grants to date for a demonstration plant, presently under construction in Thetford Mines Quebec of which $700,000 has been provided by the Government of Quebec and $5,000,000 by the Government of Canada through the Sustainable Development Technology Fund. The plant is scheduled to go into operation in mid-January 2015.
Over the last ten years DST has tested over 50 different gold deposits, both oxide and sulfide ores at the lab level and at its pilot plant. These tests have, consistently achieved gold recoveries in excess of 90{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce}, using chlorination instead of cyanide. In addition, the tailings from the process are inert from toxic substances and as result meet environmental norms. An engineering study completed within the last 12 months supports DST’s claim of having operated a pilot plant showing a gold extraction yield higher than 90{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} using a closed-circuit chlorination process.
FORWARD LOOKING STATEMENTS: This press release contains forward-looking statements that address future events and conditions, which are subject to various risks and uncertainties. Actual results could differ materially from those anticipated in such forward- looking statements as a result of numerous factors, some of which may be beyond the Corporation’s control. These factors include: results of exploration activities, general market and industry conditions, and other risks disclosed in the Corporation’s filings with Canadian Securities Regulators.
Forward-looking statements are based on the expectations and opinions of the Corporation’s management on the date the statements are made. The assumptions used in the preparation of such statements, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Corporation expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by applicable law. Depending on exploration results and available financing, the Corporation may at any point modify its work program.
The Canadian Securities Exchange has in no way passed upon the merits of the proposed transaction and has neither approved nor disapproved the contents of this press release.
Pierre Gauthier
President and CEO
(514) 866-6193
(514) 866-6001 # 244
- Published in Mining
Affinor to acquire Vancouver rooftop garden
Mr. Sebastien Plouffe reports
AFFINOR GROWERS RESCUES VANCOUVER ROOFTOP GARDEN
Affinor Growers Inc. has signed a letter of intent to acquire all the assets of 0993341 B.C. Ltd. related to the operation of the Vancouver rooftop growing facility, located at 523/535 Richards St., subject to due diligence. The intellectual property from this acquisition is very important to Affinor Growers, and will be useful in future development and production aspects.
North America’s first vertical-crop urban farming system closed operations and filed for bankruptcy after Alterrus Systems and Local Garden Vancouver failed to match their running costs. The vertical farm opened in November, 2012, in downtown Vancouver atop a parkade at 535 Richards St. According to Vancouver news sources, the 5,700-square-foot facility experienced a significant mechanical failure in late December, 2013, which impaired its ability to safely and effectively operate.
This acquisition will allow Affinor Growers to retrofit the facility and start growing strawberries immediately using the recently acquired Vertical Designs Ltd. technology. Affinor Growers will now be able to fast-track operations and demonstrate viability to the market, and add another profitable revenue stream.
This is also a great opportunity for the City of Vancouver to continue its vision of growing fresh urban food and replacing much of the imported produce that comes from 1,500 kilometres to 2,000 kilometres away. The Vancouver food strategy has a plan to create a just and sustainable food system for the city. It builds on years of food systems initiatives and grassroots community development, considering all aspects of the food system, from seed to table to compost heap and back again. Affinor Growers is excited to participate in Vancouver’s goal to become the greenest city by 2020.
Under the terms, Affinor Growers will pay a minimum of $250,000 in cash and the balance to $1.4-million in stock.
- Published in Medical Marijuana
Highmark closes first placement tranche for $349,862
HIGHMARK MARKETING INC. CLOSES FIRST TRANCHE OF NON-BROKERED PRIVATE PLACEMENT
Highmark Marketing Inc. has completed the first tranche of a non-brokered private placement by issuing 999,607 units at a price of 35 cents per unit for gross proceeds of $349,862.45. The private placement, which was announced on June 9, has a total offering of up to 1.5 million units, which are available at a price of 35 cents per unit. Each unit consists of one common share and one full share purchase warrant. Each warrant is non-transferable and is exercisable into one common share for a period of 12 months from the date of issuance at a price of 60 cents per share. The common share and full share purchase warrant are each subject to a hold period expiring on Nov. 8, 2014.
Highmark also announces that, pursuant to the terms and conditions of a non-brokered private placement agreement entered into between Highmark and Wolverton Securities Ltd., and a referral fee agreement entered into between Highmark and Mackie Research Capital Corp., Highmark has paid an aggregate cash commission of $32,086.25 to the agents, representing 10 per cent of the gross proceeds received from subscribers introduced to Highmark by the agents. In addition, Highmark has issued an aggregate of 91,675 non-transferable warrants to the agents, representing 10 per cent of the number of units sold to subscribers introduced to Highmark by the agents. Each agent’s warrant entitles the holder to purchase one share of Highmark at an exercise price of 60 cents until July 7, 2015. The agent warrants will also be subject to a hold period ending on Nov. 8, 2014.
Net proceeds of the first tranche of the private placement will be used for working capital.
We seek Safe Harbor.
Mr. Marc Branson reports
- Published in Medical Marijuana
Canadian Securities Exchange Added to OTC Markets Group’s list of “Qualified Foreign Exchanges”
CSE issuers now eligible to apply for trading on the OTCQX and OTCQB marketplaces
The Canadian Securities Exchange (“CSE”) today announced that the exchange has been included on the list of “Qualified Foreign Exchanges” by OTC Markets Group Inc. Starting immediately, interested CSE-listed companies are eligible to apply for trading on the OTCQX and OTCQB marketplaces operated by OTC Markets Group in the United States.
Richard Carleton, CEO of the CSE, commented: “We are extremely pleased with this move by our colleagues at OTC Markets Group. Eligible CSE-listed companies are now able to leverage their Canadian stock exchange listing with us to gain access to the largest public capital market in the world, expanding reach and liquidity opportunities. We look forward to working with our issuers and OTC Markets Group to increase investor access and visibility for our listed companies in the United States.”
James Black, VP of Listings Development at the CSE, added: “This additional benefit for CSE-listed companies comes on the heels of a record setting first quarter for the exchange – eclipsing previous bests for trading and listings on our listed marketplace. The addition of the CSE to the OTC Markets Group list addresses a longstanding desire for our issuers and further solidifies our value proposition for companies seeking a primary exchange listing in Canada.”
Jason Paltrowitz, Managing Director and Global Head of Business Development at OTC Markets Group Inc., also had the following remarks: “We are pleased to add CSE to our list of Qualified Foreign Exchanges. Our OTCQX and OTCQB marketplaces offer the best informed and most efficient trading for established and venture-stage international companies that are looking to increase their visibility with U.S. investors. We look forward to working with the CSE and CSE-listed companies to highlight these exciting Canadian investment opportunities in the U.S. market.”
FOR FURTHER INFORMATION PLEASE CONTACT:
Richard Carleton
CEO, CNSX Markets Inc.
416-367-7360
richard.carleton@thecse.com
About the Canadian Securities Exchange:
The Canadian Securities Exchange is the only exchange in Canada providing trading and market information services for all domestically listed instruments. Recognized as an exchange by the Ontario Securities Commission in 2004, the CSE is designed to facilitate the capital formation process for public companies through a streamlined approach to company regulation that emphasizes disclosure and the provision of efficient secondary market trading services for investors. The exchange is home to more than 200 issues covering a broad range of industry sectors.
- Published in Business
Lakeland Resources Inc. President Jonathan Armes (TSX-V:LK)
Lakeland Resources Inc. is a pure play uranium exploration company focused on the Athabasca Basin in Saskatchewan, Canada, home to some of the world’s largest and richest high-grade uranium deposits. The Company’s common shares trade on the TSX Venture Exchange under the symbol “LK”, on the OTCQX under the symbol “LRESF” and on the Frankfurt Stock Exchange under the symbol “6LL”.
- Published in Mining
Highmark Enters Into a Binding Letter of Intent to Acquire BCBUD Producers Inc.
Highmark Marketing Inc. (CSE:HMK) (“Highmark”) is pleased to announce that it has entered into a binding letter of intent (the “Letter”) with BCBUD Producers Inc. (“BCBUD”) to acquire 100{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} of the authorized share capital of BCBUD (the “Acquisition”) from BCBUD’s shareholder, Blue Moon Advertising Inc. (“Blue Moon”).
BCBUD has prepared an application to become a licensed producer (“LP”) of marijuana and has informed Highmark that it is ready to file the application (the “Application”) under the Marijuana for Medical Purposes Regulations (“MMPR”). Highmark will cover BCBUD’s business costs relating to the Application up to a maximum of $100,000.
Highmark Marketing Inc. (CSE:HMK) (“Highmark”) is pleased to announce that it has entered into a binding letter of intent (the “Letter”) with BCBUD Producers Inc. (“BCBUD”) to acquire 100{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} of the authorized share capital of BCBUD (the “Acquisition”) from BCBUD’s shareholder, Blue Moon Advertising Inc. (“Blue Moon”).
BCBUD has prepared an application to become a licensed producer (“LP”) of marijuana and has informed Highmark that it is ready to file the application (the “Application”) under the Marijuana for Medical Purposes Regulations (“MMPR”). Highmark will cover BCBUD’s business costs relating to the Application up to a maximum of $100,000.
BCBUD has an option to lease a 27,000 square foot building in the Township of Langley, British Columbia. The property is zoned M-2, and when the facility is operational it could be capable of producing up to 2,000,000 grams (4409 pounds) of medical marijuana per year with the additional possibility of expansion adjacent to the site.
BCBUD cannot legally become a producer under the MMPR Act until it has been granted a license, and it is currently not known if and when BCBUD will obtain that license. The key milestones to obtaining a LP license include filing an application, receiving a “Ready to Build” notice, completion of the upgrades as per the application, approval to produce upon inspection of the facility, and finally approval to distribute the product to patients. Bill Marshall, President of BCBUD, has gained extensive experience with MMPR applications while working with one of the most prolific consultants to prospective licensed producers. As the Senior Person in Charge he will be responsible for advancing the application in a timely fashion, and will have the support of the Highmark team during this process. Highmark has agreed to issue 250,000 Common Shares of Highmark to Blue Moon at the time the Application has been filed by BCBUD with Health Canada.
Once the “Ready-to-Build” notice has been received from Health Canada, Highmark will have 3 months to complete the Acquisition by issuing 2,250,000 Common Shares of Highmark to Blue Moon (the “Acquisition Shares”). If Highmark completes the Acquisition, it has committed to funding another $1,500,000 for upgrading the security, electrical, plumbing, ventilation and other improvements as per the application. At the point of receiving the “Ready to Build” notice Highmark intends to seek an equity financing in the amount of $1,500,000 to meet its obligations. In the event that a license to produce marijuana is not received within 18 months, the Acquisition Shares may be subject to cancelation.
About Highmark
Highmark is a nutraceutical company, based in British Columbia, focused on bringing the health benefits of natural and herbal remedies to the market. Highmark intends to acquire, license, distribute, and market products in the nutraceutical industry.
Further information about Highmark is available under its profile on the SEDAR websitewww.sedar.com and on Highmark’s page on the CSE website.
The CSE has not reviewed, nor approved or disapproved the content of this press release.
Forward-Looking Information:
This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of Highmark. Forward-looking information is based on certain key expectations and assumptions made by the management of Highmark, including future plans for acquisitions. Although Highmark believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because Highmark can give no assurance that they will prove to be correct. Forward-looking statements contained in this press release are made as of the date of this press release. Highmark disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.
This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been and will not be registered under the United States Securities Act of 1933, as amended, or any applicable securities laws or any state of the United States and may not be offered or sold in the United States or to the account or benefit of a person in the United States absent an exemption from the registration requirements.
Highmark Marketing Inc.
Marc Branson
Chief Executive Officer
604.283.1722
info@highmarkcorp.ca
- Published in Medical Marijuana
- 1
- 2